Red cell interactions with amyloid-beta(1-40) fibrils in a murine model
- PMID: 15837558
- DOI: 10.1016/j.nbd.2004.11.004
Red cell interactions with amyloid-beta(1-40) fibrils in a murine model
Abstract
Vascular amyloidosis in Alzheimer's disease (AD) results in the exposure of red blood cells to beta-amyloid fibrils (A beta). The potential in vivo ramifications of this exposure have been investigated by injecting A beta(1-40) alone or A beta-bound mouse red blood cells into the circulation of C57BL/6 mice. Results indicate that when A beta(1-40) is injected alone, a transient uptake of the fibrils by red blood cells occurs in vivo. When A beta-bound red blood cells were injected, beta-amyloid is rapidly removed from these cells in vivo. Double-labeling experiments indicate that while some of the red blood cells bound to A beta(1-40) are removed from circulation, a major fraction of these cells remain in circulation even after A beta is removed. Immunohistochemistry of murine tissue samples obtained after sacrificing the animals suggests that within 1 h after injection of A beta(1-40) or A beta-bound red blood cells, A beta is found in spleen phagocytes and liver Kupffer cells. Heme staining further indicates that the binding of A beta(1-40) to red blood cells enhances red cell phagocytosis by the spleen.
Similar articles
-
Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.J Neurochem. 2006 Mar;96(5):1322-35. doi: 10.1111/j.1471-4159.2005.03647.x. J Neurochem. 2006. PMID: 16478525
-
Abeta-globulomers are formed independently of the fibril pathway.Neurobiol Dis. 2008 May;30(2):212-20. doi: 10.1016/j.nbd.2008.01.010. Epub 2008 Feb 15. Neurobiol Dis. 2008. PMID: 18353662
-
Chronic treatment with amyloid beta(1-42) inhibits non-cholinergic high-affinity choline transport in NG108-15 cells through protein kinase C signaling.Brain Res. 2005 Nov 16;1062(1-2):101-10. doi: 10.1016/j.brainres.2005.09.021. Epub 2005 Oct 26. Brain Res. 2005. PMID: 16256077
-
Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.Behav Brain Res. 2007 Feb 27;177(2):205-13. doi: 10.1016/j.bbr.2006.11.032. Epub 2006 Dec 27. Behav Brain Res. 2007. PMID: 17194489
-
Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.Neurodegener Dis. 2008;5(3-4):140-2. doi: 10.1159/000113684. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322372 Review.
Cited by
-
Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer's Disease.Int J Mol Sci. 2024 Oct 11;25(20):10964. doi: 10.3390/ijms252010964. Int J Mol Sci. 2024. PMID: 39456746 Free PMC article. Review.
-
Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease.Neurobiol Aging. 2008 Feb;29(2):185-93. doi: 10.1016/j.neurobiolaging.2006.10.017. Epub 2006 Dec 8. Neurobiol Aging. 2008. PMID: 17157413 Free PMC article.
-
Plasmodium falciparum merozoite surface protein 3: oligomerization, self-assembly, and heme complex formation.J Biol Chem. 2014 Feb 14;289(7):3856-68. doi: 10.1074/jbc.M113.520239. Epub 2013 Dec 19. J Biol Chem. 2014. PMID: 24362023 Free PMC article.
-
Impact of amyloid β25-35 on membrane stability, energy metabolism, and antioxidant enzymes in erythrocytes.Am J Alzheimers Dis Other Demen. 2014 Dec;29(8):685-95. doi: 10.1177/1533317514534757. Epub 2014 May 16. Am J Alzheimers Dis Other Demen. 2014. PMID: 24838531 Free PMC article.
-
ApoHRP-based assay to measure intracellular regulatory heme.Metallomics. 2015 Feb;7(2):309-21. doi: 10.1039/c4mt00246f. Metallomics. 2015. PMID: 25525887 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources